{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:31Z","timestamp":1792782691685,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302046"],"award-info":[{"award-number":["81302046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730003"],"award-info":[{"award-number":["81730003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Jiangsu Province","award":["BL20171205"],"award-info":[{"award-number":["BL20171205"]}]},{"name":"Innovation Capability Development Project of Jiangsu Province","award":["BM2015004"],"award-info":[{"award-number":["BM2015004"]}]},{"name":"National Key R&D Program of China","award":["2016YFC0902800"],"award-info":[{"award-number":["2016YFC0902800"]}]},{"name":"National Key R&D Program of China","award":["2017YFA0104502"],"award-info":[{"award-number":["2017YFA0104502"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00277-018-3432-4","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T13:52:27Z","timestamp":1533736347000},"page":"2061-2070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases"],"prefix":"10.1007","volume":"97","author":[{"given":"Biqi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiemei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aining","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"3432_CR1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.V81.7.1675.1675","volume":"81","author":"RG Strauss","year":"1993","unstructured":"Strauss RG (1993) Therapeutic granulocyte transfusions in 1993. Blood 81:1675\u20131678","journal-title":"Blood"},{"key":"3432_CR2","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","volume":"126","author":"TH Price","year":"2015","unstructured":"Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JAH, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF (2015) Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u2013treated donors in neutropenic patients with infection. Blood 126:2153\u20132161","journal-title":"Blood"},{"key":"3432_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00043426-199911000-00006","volume":"21","author":"RG Strauss","year":"1999","unstructured":"Strauss RG (1999) Rebirth of granulocyte transfusions: should it involve pediatric oncology and transplant patients? J Pediatr Hematol Oncol 21:475\u2013478","journal-title":"J Pediatr Hematol Oncol"},{"key":"3432_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/j.1537-2995.2006.00996.x","volume":"46","author":"UJ Sachs","year":"2006","unstructured":"Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W (2006) Safety and efficacy of theraputic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 46:1909\u20131914","journal-title":"Transfusion"},{"key":"3432_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12967-015-0724-5","volume":"13","author":"C Cugno","year":"2015","unstructured":"Cugno C, Deola S, Filippini P, Stroncek DF, Rutella S (2015) Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies. J Transl Med 13:362","journal-title":"J Transl Med"},{"key":"3432_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/MPH.0b013e318196a6f9","volume":"31","author":"MG Seidel","year":"2009","unstructured":"Seidel MG, Minkov M, Witt V, Matthes-Martin S, P\u00f6tschger U, Worel N, Leitner G, Stary J, Gadner H, Peters C (2009) Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol 31:166\u2013172","journal-title":"J Pediatr Hematol Oncol"},{"key":"3432_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-016-2774-y","volume":"175","author":"C Weingarten","year":"2016","unstructured":"Weingarten C, Pliez S, Tschiedel E et al (2016) Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis. Eur J Pediatr 175:1\u20139","journal-title":"Eur J Pediatr"},{"key":"3432_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/(SICI)1098-1101(1997)12:2<74::AID-JCA4>3.0.CO;2-6","volume":"12","author":"EC Vamvakas","year":"1997","unstructured":"Vamvakas EC, Pineda AA (1997) Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apher 12:74\u201381","journal-title":"J Clin Apher"},{"key":"3432_CR9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/sj.leu.2400811","volume":"11","author":"MC Dignani","year":"1997","unstructured":"Dignani MC, Anaissie EJ, Hester JP, O\u2019Brien S, Vartivarian SE, Rex JH, Kantarjian H, Jendiroba DB, Lichtiger B, Andersson BS, Freireich EJ (1997) Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 11:1621\u20131630","journal-title":"Leukemia"},{"key":"3432_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1389450117666160201113612","volume":"17","author":"D Averbuch","year":"2016","unstructured":"Averbuch D, Engelhard D, Pegoraro A, Cesaro S (2016) Review on efficacy and complications of granulocyte transfusions in neutropenic patients. Curr Drug Targets 17:1\u20131","journal-title":"Curr Drug Targets"},{"key":"3432_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","volume":"84","author":"S Mousset","year":"2005","unstructured":"Mousset S, Stella H, Stefan AK et al (2005) Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 84:734\u2013741","journal-title":"Ann Hematol"},{"key":"3432_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2141.1999.01619.x","volume":"106","author":"C Peters","year":"1999","unstructured":"Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, Hocker P, Worel N, Stary J, Klingebiel T, Gadner H (1999) Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 106:689\u2013696","journal-title":"Br J Haematol"},{"key":"3432_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/bmt.2008.237","volume":"42","author":"MG Seidel","year":"2008","unstructured":"Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, Silling G, Grimminger W, Einsele H (2008) Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 42:679\u2013684","journal-title":"Bone Marrow Transplant"},{"key":"3432_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/00365548.2012.714906","volume":"45","author":"H Cherif","year":"2013","unstructured":"Cherif H, Axdorph U, Kalin M, Bj\u00f6rkholm M (2013) Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection. Scand J Infect Dis 45:112\u2013116","journal-title":"Scand J Infect Dis"},{"key":"3432_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, de Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377","journal-title":"Intensive Care Med"},{"key":"3432_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"key":"3432_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciw504","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratal\u00e0 J, el Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:575\u2013582","journal-title":"Clin Infect Dis"},{"key":"3432_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","volume":"42","author":"K H\u00fcbel","year":"2002","unstructured":"H\u00fcbel K, Carter RA, Liles WC et al (2002) Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 42:1414\u20131421","journal-title":"Transfusion"},{"key":"3432_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood-2011-10-345751","volume":"119","author":"D O'Donghaile","year":"2012","unstructured":"O'Donghaile D, Childs RW, Leitman SF (2012) Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation. Blood 119:1353\u20131355","journal-title":"Blood"},{"key":"3432_CR20","doi-asserted-by":"publisher","first-page":"e88148","DOI":"10.1371\/journal.pone.0088148","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang H, Wu Y, Fu R, Qu W, Ruan E, Wang G, Liu H, Song J, Xing L, Guan J, Li L, Liu C, Shao Z (2014) Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China. PLoS One 9:e88148","journal-title":"PLoS One"},{"key":"3432_CR21","first-page":"503","volume":"22","author":"P Mannoni","year":"1979","unstructured":"Mannoni P, Rodet M, Vernant JP, Brun B, Coquin-Radeau EI, Bracq C, Rochant H, Dreyfus B (1979) Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia. Rev Fr Transfus Immunohematol 22:503\u2013518","journal-title":"Rev Fr Transfus Immunohematol"},{"key":"3432_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/1097-0142(1984)54:4<734::AID-CNCR2820540424>3.0.CO;2-W","volume":"54","author":"JL Gomez-Villagran","year":"1984","unstructured":"Gomez-Villagran JL, Torres-Gomez A, Gomez-Garcia P, Martinez-Guibelalde F, Velasco-Jimena F (1984) A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia. Cancer 54:734\u2013738","journal-title":"Cancer"},{"key":"3432_CR23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1056\/NEJM197805112981904","volume":"298","author":"RA Clift","year":"1978","unstructured":"Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 298:1052\u20131057","journal-title":"N Engl J Med"},{"key":"3432_CR24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1182\/blood-2010-04-278135","volume":"117","author":"BH Shaz","year":"2011","unstructured":"Shaz BH, Stowell SR, Hillyer CD (2011) Transfusion-related acute lung injury: from bedside to bench and back. Blood 117:1463\u20131471","journal-title":"Blood"},{"key":"3432_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/bmt.2012.187","volume":"48","author":"SE Lee","year":"2013","unstructured":"Lee SE, Cho BS, Kim JH, Yoon JH, Shin SH, Yahng SA, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW (2013) Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transplant 48:587\u2013592","journal-title":"Bone Marrow Transplant"},{"key":"3432_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","volume":"100","author":"MED Flowers","year":"2002","unstructured":"Flowers MED, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100:415\u2013419","journal-title":"Blood"},{"key":"3432_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood-2001-11-0059","volume":"100","author":"M Zecca","year":"2002","unstructured":"Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F, AIEOP-BMT Group. Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 100:1192\u20131200","journal-title":"Blood"},{"key":"3432_CR28","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty J, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network (2012) Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 367:1487\u20131496","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T21:18:36Z","timestamp":1571692716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3432-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"23 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in compliance with the institutional policy regarding the protection of patients\u2019 private information and approved by the Research Ethics Committee of the First Affiliated Hospital of Soochow University. All the methods were carried out in accordance with the approval guidelines of The First Affiliated Hospital of Soochow University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}